aTyr Pharma

aTyr has built and intellectual property portfolio covering >300 protein compositions derived from all 20 tRNA synthetase genes, and is engaged in the discovery and development of potential first-in-class medicines based on newly discovered pathways effected by extracellular tRNA synthetases. This is the 3rd generation website AldenMC has developed for aTyr. We are currently refreshing their corporate brand identity and website. It has been an honor to assist in the messaging and communication of  aTyrs’ incredible journey as they develop best-in-class medicines.